Stock 002898 SAILONG PHARMACEUTICAL GROUP CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

News Sailong Pharmaceutical Group Co.,Ltd.

Equities

002898

CNE1000032S5

End-of-day quote Shenzhen S.E.
Other stock markets
 23:00:00 14/05/2024 BST 		5-day change 1st Jan Change
10.19 CNY -2.02% Intraday chart for Sailong Pharmaceutical Group Co.,Ltd. -4.14% -27.06%
04-19 Sailong Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-08 Sailong Pharmaceutical Group Co.,Ltd. Approves Board Elections CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Sailong Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Sailong Pharmaceutical Group Co.,Ltd. Approves Board Elections
CI
Sailong Pharma's Unit Gets Nod to Market Pregabalin
MT
Sailong Pharma Gets Registration Certificate for Pregabalin Capsules
MT
Sailong Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Sailong Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Sailong Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Sailong Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Sailong Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
CI
Sailong Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
CI
Sailong Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
Sailong Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021
CI
Zhuhai Sailong Pharmaceutical : Sailong Pharmaceutical Adopts New Name
MT
Zhuhai Sailong Pharmaceutical Co.,Ltd. has Changed its Name to Sailong Pharmaceutical Group Co., Ltd
CI
Zhuhai Sailong Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021
CI
Wu Gulin signed share transfer agreement to acquire Hunan Shenglong Real Estate Co., Ltd. from Zhuhai Sailong Pharmaceutical Co.,Ltd. for CNY 10.2 million.
CI
Zhuhai Sailong Pharmaceutical Co.,Ltd. Proposes No Final Dividend for 2020
CI
Zhuhai Sailong Pharmaceutical Co.,Ltd. Announces Earnings Results for the First Quarter Ended March 31, 2021
CI
Zhuhai Sailong Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020
CI
Zhuhai Sailong Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2020
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 002898 Stock
  4. News Sailong Pharmaceutical Group Co.,Ltd.